Author Question: What is the 5-year survival rate for patients with untreated idiopathic pulmonary artery ... (Read 48 times)

mydiamond

  • Hero Member
  • *****
  • Posts: 804
What is the 5-year survival rate for patients with untreated idiopathic pulmonary artery hyperten-sion (IPAH)?
 
  a. 33
  b. 44
  c. 55
  d. 66

Question 2

What is the most common pulmonary function abnormality found in patients with idiopathic pulmonary artery hypertension (IPAH)?
 
  a. Reduced diffusing capacity of the lungs (DLCO)
  b. Reduced forced vital capacity (FVC)
  c. Reduced forced expiratory flow (FEF25 to 75)
  d. Reduced lung compliance (CL)



aloop

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

ANS: A
IPAH can be life threatening and carries a poor prognosis. Without therapy, only 33 of patients are alive 5 years after the onset of the disorder.

Answer to Question 2

ANS: A
Pulmonary function tests are useful to rule out the presence of significant restrictive or obstruc-tive airway disease. The most common abnormality at pulmonary function testing of patients with IPAH is a low carbon monoxide diffusing capacity (DLCO).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

The B-complex vitamins and vitamin C are not stored in the body and must be replaced each day.

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

The longest a person has survived after a heart transplant is 24 years.

For a complete list of videos, visit our video library